CME Group (CME)
(Delayed Data from NSDQ)
$280.76 USD
+2.48 (0.89%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $280.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CME 280.76 +2.48(0.89%)
Will CME be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CME based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CME
Cboe Global Q2 Earnings Surpass Estimates on Higher Revenues
Intercontinental Exchange Q2 Earnings & Revenues Top Estimates
CME: What are Zacks experts saying now?
Zacks Private Portfolio Services
NDAQ Beats Q2 Earnings & Revenue Estimates, Tweaks Expense View
Top Cryptocurrency Stocks to Buy Amid Regulatory Tailwinds
CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume
Other News for CME
Built To Last: My 16-Stock Dividend Pyramid Portfolio
Decoding CME Group Inc (CME): A Strategic SWOT Insight
SoFi: Meme Stock Phenom, Crypto And Private Equity
CME Group (CME) Wins Legal Battle: Jury Rules in Favor of the Company
CME Group (CME) Downgraded to Neutral by UBS Amid Activity Slowdown